Infectious diseases: annual review of significant publications.
D000257:Adenoviridae Infections; D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002771:Cholera; D003047:Coccidioidomycosis; D003141:Communicable Diseases; D003165:Complement System Proteins; D003587:Cytomegalovirus; D004403:Dysentery; D004405:Dysentery, Bacillary; D004660:Encephalitis; D004697:Endocarditis, Bacterial; D006506:Hepatitis A; D006561:Herpes Simplex; D006564:Herpesviridae; D006660:Histoplasmosis; D006801:Humans; D007223:Infant; D007251:Influenza, Human; D007372:Interferons; D008581:Meningitis; D008590:Meningoencephalitis; D009175:Mycoplasma Infections; D011014:Pneumonia; D012409:Rubella; D012899:Smallpox; D013290:Streptococcal Infections; D019966:Substance-Related Disorders; D014068:Tonsillectomy; D014376:Tuberculosis; D014435:Typhoid Fever; D014552:Urinary Tract Infections; D014777:Virus Diseases
D000900:Anti-Bacterial Agents; D003165:Complement System Proteins; D007372:Interferons